China digital PCR (dPCR) and real-time PCR (qPCR) market is estimated to grow at a CAGR of 9.3% during the forecast period. The market in China has both medium and long-term potential owing to the increasing prevalence of chronic diseases and the large aging population base. Furthermore, the Chinese economy is becoming an R&D-intensive economy on all fronts, which is the major factor for the growth of the life science industry in China. An aging population and the growing prevalence of cancer among youth and middle age population are resulting in the growth of the life science industry in China. 

According to the World Health Organization (WHO), China recorded nearly 4.3 million cancer cases in 2018. China is one of the major countries with considerable biologics production. The Chinese market generates much of the revenue from the largest life science companies across the globe. Droplet digital PCR (ddPCR) has become one of the most accurate and reliable tools to study genetic alterations in a broad range of cancers owing to its high sensitivity and specificity. Therefore, it has a crucial application in cancer drug development, which in turn, is driving the growth of the market.

In addition, the increasing interest of multinational pharmaceutical companies is another major factor that is fueling the growth of the dPCR and qPCR market. For instance, Bayer Healthcare has signed a deal with the Tsinghua University of Beijing for multiple joint research projects for innovative drug discovery. Further, other ongoing research partnerships between Bayer and the Chinese Academy of Sciences aim to improve the academic exchange in R&D and mutual access to research facilities. These are the major factors that are driving the growth of dPCR and qPCR market in the country.

The companies operating in the market include Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, QIAGEN N.V., and Hangzhou Longgene Scientific Instruments Co., Ltd. The growth strategies adopted by these players such as acquisitions, mergers, investment in R&D activities and product launches are estimated to have a positive impact on the growth of the PCR technologies such as dPCR and qPCR in the country. For instance, in November 2018, Thermo Fisher Scientific, opened its first Bioprocess Design Center in Shanghai, China. It is part of a strategy to set up a center of excellence where the scientists of the company can connect and partner with biologic developers to design optimal bioprocessing solutions.

Research Methodology

The market study of the China dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. China dPCR and qPCR Market Research and Analysis, By Technology
2. China dPCR and qPCR Market Research and Analysis, By Product
3. China dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

• Comprehensive research methodology of the China dPCR and qPCR market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the China dPCR and qPCR market.
• Insights about market determinants which are stimulating the China dPCR and qPCR market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.